Detalhe da pesquisa
1.
Network meta-analysis of drug-coated balloon angioplasty versus primary nitinol stenting for femoropopliteal atherosclerotic disease.
J Vasc Surg
; 73(5): 1802-1810.e4, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33249205
2.
Infections during peginterferon/ribavirin therapy are associated with the magnitude of decline in absolute lymphocyte count: results of the IDEAL study.
Clin Infect Dis
; 58(7): 960-9, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24399086
3.
Pegylated interferon fractal pharmacokinetics: individualized dosing for hepatitis C virus infection.
Antimicrob Agents Chemother
; 57(3): 1115-20, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23183434
4.
Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail?
Am J Gastroenterol
; 108(3): 425-32, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23337478
5.
Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C.
Gastroenterology
; 140(3): 840-9; quiz e12, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21129375
6.
A single nucleotide polymorphism in IL28B affects viral evolution of hepatitis C quasispecies after pegylated interferon and ribavirin therapy.
J Med Virol
; 84(12): 1913-9, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23080496
7.
Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon.
Hepatology
; 53(4): 1100-8, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21480316
8.
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.
Hepatology
; 54(2): 396-405, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21520194
9.
Hepatitis C therapy update.
Curr Opin Gastroenterol
; 28(3): 188-92, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22476156
10.
Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C.
Gastroenterology
; 138(7): 2321-31, 2331.e1-2, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20211180
11.
Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate.
Gastroenterology
; 139(5): 1602-11, 1611.e1, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20723545
12.
Development and progression of portal hypertensive gastropathy in patients with chronic hepatitis C.
Am J Gastroenterol
; 106(5): 884-93, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21139575
13.
Outcome of sustained virological responders with histologically advanced chronic hepatitis C.
Hepatology
; 52(3): 833-44, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20564351
14.
Update of chronic hepatitis B.
Curr Opin Gastroenterol
; 27(3): 217-23, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21423004
15.
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.
Gastroenterology
; 136(1): 138-48, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18848939
16.
Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.
Gastroenterology
; 137(6): 1986-94, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19747918
17.
Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
Hepatology
; 49(6): 1828-37, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19291787
18.
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.
Hepatology
; 50(5): 1360-9, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19676128
19.
Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders.
Hepatology
; 50(6): 1719-26, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19852040
20.
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.
Hepatology
; 49(6): 1847-58, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19434718